drugset / Trial / NCT07198347
Efficacy and Safety of AG2001 in Patients With Acute Bronchitis
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a Phase 3, randomized, double-blind, active-controlled clinical trial designed to evaluate the efficacy and safety of AG2001 in patients with acute bronchitis. The primary objective is to demonstrate the superiority of AG2001 over two active comparators based on the change in Bronchitis Severity Score (BSS) at Day 4.
Timeline
- Start
- 2025-11-01
- Primary completion
- 2026-03-31
- Completion
- 2026-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AG2001 | Unknown | — | Oral |
| Comparator | AG20011 | Unknown | — | Oral |
| Comparator | AG20012 | Unknown | — | Oral |